130 related articles for article (PubMed ID: 23573650)
1. Overview of clinical trials.
Cannon C
J Invasive Cardiol; 2004 Sep; 16 Suppl E():7E-10E. PubMed ID: 23573650
[No Abstract] [Full Text] [Related]
2. ACE inhibitors in acute myocardial infarction.
Murdoch DR; McMurray JJ
Hosp Med; 1998 Feb; 59(2):111-5. PubMed ID: 9797884
[TBL] [Abstract][Full Text] [Related]
3. Update on pharmacological advances.
Fonarow G
J Invasive Cardiol; 2004 Sep; 16 Suppl E():2E-6E. PubMed ID: 23573649
[No Abstract] [Full Text] [Related]
4. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
5. Trandolapril in patients with left ventricular dysfunction after myocardial infarction.
Neumayr G; Gänzer J
N Engl J Med; 1996 Jun; 334(23):1546. PubMed ID: 8618619
[No Abstract] [Full Text] [Related]
6. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
Weir R; McMurray JJ
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
[TBL] [Abstract][Full Text] [Related]
7. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
Køber L; Torp-Pedersen C; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J; Cole DS; Auclert L; Pauly NC
N Engl J Med; 1995 Dec; 333(25):1670-6. PubMed ID: 7477219
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular dysfunction: causes, natural history, and hopes for reversal.
Armstrong PW
Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i15-7:discussion i50. PubMed ID: 10956313
[No Abstract] [Full Text] [Related]
9. Beta-adrenergic blocking agents or angiotensin-converting enzyme inhibitors, or both, for postinfarction patients with left ventricular dysfunction.
O'Rourke RA
J Am Coll Cardiol; 1997 Feb; 29(2):237-9. PubMed ID: 9014972
[No Abstract] [Full Text] [Related]
10. [Neurohumoral systems escape control. Heart failure symptoms even once--long-term high risk prognosis].
MMW Fortschr Med; 2005 Jul; 147(27-28):45. PubMed ID: 16041943
[No Abstract] [Full Text] [Related]
11. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
Azadpour M; Lamas GA
Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].
Kubota T; Takeshita A
Nihon Rinsho; 2003 May; 61(5):801-6. PubMed ID: 12755006
[TBL] [Abstract][Full Text] [Related]
13. Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction.
Aronow WS; Ahn C; Kronzon I
Am J Cardiol; 2001 Dec; 88(11):1298-300. PubMed ID: 11728359
[No Abstract] [Full Text] [Related]
14. Current concepts for the neurohormonal management of left ventricular dysfunction after myocardial infarction.
Shah KB; Gottlieb SS
Curr Heart Fail Rep; 2004 Dec; 1(4):161-7. PubMed ID: 16036040
[TBL] [Abstract][Full Text] [Related]
15. ACE inhibitors after myocardial infarction.
Jackson G
Br J Clin Pract; 1995; 49(4):171. PubMed ID: 7547152
[No Abstract] [Full Text] [Related]
16. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic therapies across the continuum of left ventricular dysfunction.
Abraham WT; Greenberg BH; Yancy CW
Am J Cardiol; 2008 Sep; 102(5A):21G-28G. PubMed ID: 18722188
[TBL] [Abstract][Full Text] [Related]
18. The pharmacological treatment of heart failure: are we looking at the sunset of the neurohormonal hypothesis.
Porcu M
Ital Heart J; 2002 Jul; 3(7):437-8. PubMed ID: 12189976
[No Abstract] [Full Text] [Related]
19. Recognizing and managing asymptomatic left ventricular dysfunction after myocardial infarction.
Albert NM; Lewis C
Crit Care Nurse; 2008 Apr; 28(2):20-37; quiz 38. PubMed ID: 18378726
[No Abstract] [Full Text] [Related]
20. The use of angiotensin converting enzyme inhibitors in asymptomatic patients with left ventricular dysfunction after myocardial infarction.
Bazunga M
Conn Med; 1995 Nov; 59(11):663-6. PubMed ID: 8565511
[No Abstract] [Full Text] [Related]
[Next] [New Search]
